The association between HPV status and the development of persistent HPV infection (ever) in SLE.
| HPV Status | No. of Patients | Persistent HPV | Transient or Negative HPV | Unadjusted OR (95% CI) |
|---|---|---|---|---|
| HPV positive at baseline | ||||
| Yes | 15 | 10 | 5 | 38.0 (9.8–146.8) |
| No | 120 | 6 | 114 | |
| HPV positive ever | ||||
| Yes | 31 | 16 | 15 | — |
| No | 104 | 0 | 104 | |
| HPV > 1 at baseline | ||||
| Yes | 9 | 7 | 2 | 45.5 (8.2–251.9) |
| No | 126 | 9 | 117 | |
| HPV > 1 at first incident infection | ||||
| Yes | 15 | 11 | 4 | 63.3 (14.8–270.5) |
| No | 120 | 5 | 115 | |
| HPV > 1 ever | ||||
| Yes | 20 | 14 | 6 | 131.8 (24.2–717.3) |
| No | 115 | 2 | 113 | |
| High-risk HPV baseline | ||||
| Yes | 13 | 9 | 4 | 37.0 (9.1–150.4) |
| No | 122 | 7 | 115 | |
| High-risk HPV ever | ||||
| Yes | 25 | 15 | 10 | 163.5 (19.5–1369.4) |
| No | 110 | 1 | 109 |
All p values < 0.001. OR could not be estimated since only HPV-positive patients would have persistent HPV infection. HPV: human papilloma virus.